Nasal Filter Alleviates Hay Fever Symptoms
|
By HospiMedica International staff writers Posted on 25 Mar 2014 |

Image: The Rhinix mini-filter for nasal insertion (Photo courtesy of Aarhus University).
A small filter the size of a contact lens could make life easier for some of the estimated 500 million people worldwide who suffer from seasonal allergic rhinitis (hay fever).
Under development by researchers at Aarhus University (Denmark), the Rhinix mini-filter is designed to be inserted in both nostrils simultaneously, and can be used both in professional and social settings, as well as during sleep. Depending on the filter's density, it can block specific particles in the air, including pollen from grass, which is one of the most frequent causes of hay fever. When inserted correctly the filter is nearly invisible.
The researchers conducted a single-center, randomized placebo-controlled crossover clinical trial in an environmental exposure unit (EEU) at Aarhus University on 24 subjects with proven seasonal allergic rhinitis due to allergy to grass. A total nasal symptom score (TNSS), consisting of nasal congestion, nasal discharge, nasal itching, and sneezing was used as the primary outcome measure. TNSS was rated nine times during each study day and evaluated based on the difference in daily TNSS and maximum daily TNSS.
The results showed that Rhinix reduced daily TNSS by 21%, daily sneezing by 45%, maximum itching by 46%, and maximum sneezing by 38%, when compared to placebo. Conversly, Rhinix showed a nonsignificant reduction in the primary efficacy endpoint of difference in maximum TNSS, with a mean reduction of 14% and median reduction of 33% when compared to placebo. The nasal filters were well tolerated and measurements showed that there was no difference in airflow between the placebo filter and the Rhinix filter. The study was published online on March 3, 2014, in the Journal of Allergy and Clinical Immunology.
“We will test Rhinix on a larger scale in collaboration with the Danish Patient Organization Asthma-Allergy Denmark later in the year,” said seniorstudy author Prof. Torben Sigsgaard, MD, PhD. “But the preliminary tests in our allergy chamber show that the filter can both alleviate typical symptoms and that you will not experience unacceptable discomfort when using it.”
Allergic rhinitis is an allergic inflammation of the nasal airways. It occurs when an allergen, such as pollen, dust, or animal dander is inhaled by an individual with a sensitized immune system. In such individuals, the allergen triggers the production of the antibody immunoglobulin E (IgE), which binds to mast cells and basophils containing histamine. When caused by pollens of any plants, it is called pollinosis, and, if specifically caused by grass pollens, it is known as hay fever. While symptoms resembling a cold or flu can be produced by an allergic reaction to pollen from plants and grasses, including those used to make hay, it does not cause a fever.
Related Links:
Aarhus University
Under development by researchers at Aarhus University (Denmark), the Rhinix mini-filter is designed to be inserted in both nostrils simultaneously, and can be used both in professional and social settings, as well as during sleep. Depending on the filter's density, it can block specific particles in the air, including pollen from grass, which is one of the most frequent causes of hay fever. When inserted correctly the filter is nearly invisible.
The researchers conducted a single-center, randomized placebo-controlled crossover clinical trial in an environmental exposure unit (EEU) at Aarhus University on 24 subjects with proven seasonal allergic rhinitis due to allergy to grass. A total nasal symptom score (TNSS), consisting of nasal congestion, nasal discharge, nasal itching, and sneezing was used as the primary outcome measure. TNSS was rated nine times during each study day and evaluated based on the difference in daily TNSS and maximum daily TNSS.
The results showed that Rhinix reduced daily TNSS by 21%, daily sneezing by 45%, maximum itching by 46%, and maximum sneezing by 38%, when compared to placebo. Conversly, Rhinix showed a nonsignificant reduction in the primary efficacy endpoint of difference in maximum TNSS, with a mean reduction of 14% and median reduction of 33% when compared to placebo. The nasal filters were well tolerated and measurements showed that there was no difference in airflow between the placebo filter and the Rhinix filter. The study was published online on March 3, 2014, in the Journal of Allergy and Clinical Immunology.
“We will test Rhinix on a larger scale in collaboration with the Danish Patient Organization Asthma-Allergy Denmark later in the year,” said seniorstudy author Prof. Torben Sigsgaard, MD, PhD. “But the preliminary tests in our allergy chamber show that the filter can both alleviate typical symptoms and that you will not experience unacceptable discomfort when using it.”
Allergic rhinitis is an allergic inflammation of the nasal airways. It occurs when an allergen, such as pollen, dust, or animal dander is inhaled by an individual with a sensitized immune system. In such individuals, the allergen triggers the production of the antibody immunoglobulin E (IgE), which binds to mast cells and basophils containing histamine. When caused by pollens of any plants, it is called pollinosis, and, if specifically caused by grass pollens, it is known as hay fever. While symptoms resembling a cold or flu can be produced by an allergic reaction to pollen from plants and grasses, including those used to make hay, it does not cause a fever.
Related Links:
Aarhus University
Latest Critical Care News
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







